Table 1 Demographic, clinical, and laboratory data at baseline in 8,954 patients on peritoneal dialysis.
From: Predictors of outcomes in patients on peritoneal dialysis: A 2-year nationwide cohort study
Variable | |
|---|---|
Patients (n) | 8,954 |
Age (years) | 62.7 ± 13.1 |
Male sex (%) | 63.8 |
Dialysis duration (months) | 33 [15–60] |
Primary cause of ESKD, n (%) | |
Chronic glomerulonephritis | 3,513 (39.2) |
Diabetic nephropathy | 2,710 (30.3) |
Hypertension | 1,154 (12.9) |
Polycystic kidney disease | 223 (2.5) |
Other | 476 (5.3) |
Unknown | 878 (9.8) |
Body mass index (kg/m2) | 23.4 ± 3.8 |
Smoking (%) | 8.1 |
Antihypertensive agents (%) | 79.2 |
Comorbid CVD (%) | 15.1 |
Hemoglobin (g/dL) | 10.8 ± 1.4 |
Albumin (g/dL) | 3.3 ± 0.5 |
Non-HDL cholesterol (mg/dL) | 128 ± 37 |
HDL cholesterol (mg/dL) | 50 ± 18 |
C-reactive protein (mg/dL) | 0.13 [0.07–0.40] |
Calcium (mg/dL) | 8.7 ± 0.8 |
Phosphate (mg/dL) | 5.2 ± 1.3 |
Intact PTH (pg/mL) | 155 [81–262] |
Renal Kt/V | 0.3 [0–0.8] |
PD Kt/V | 1.4 ± 0.6 |
Total Kt/V | 1.8 ± 0.8 |
D/P Cr | 0.65 ± 0.13 |
Use of 2.5% glucose dialysate (%) | 37.5 |
Use of icodextrin (%) | 40.8 |
Use of automated PD (%) | 43.2 |
Connecting system (%) | |
Device (+) | 68.2 |
PD + HD combination (%) | 18.8 |
